No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. — المؤلف: Robinson, Katherine M — Pediatric blood & cancer 20191218
- المؤلف
- Robinson, Katherine M
- النشر
- Pediatric blood & cancer 20191218
- الوصف
- e27681 p.
- الموضوعات
- Antibiotics, Antineoplastic؛ Child؛ Cohort Studies؛ Daunorubicin؛ Female؛ Follow-Up Studies؛ Glucosephosphate Dehydrogenase؛ Humans